Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo

miR-101–3p may play a therapeutic role in various tumours. However, its anti-tumour mechanism remains unclear, and a definitive strategy to treat tumour cells in vivo is lacking. The objective of this study was to investigate the inhibitory mechanism of miR-101–3p on tumour cells and to develop rele...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Redox Biol
Main Authors: Luo, Yifeng, Niu, Gang, Yi, Hui, Li, Qingling, Wu, Zhiqiang, Wang, Jing, Yang, Juan, Li, Bo, Peng, Yuan, Liang, Ying, Wang, Weiwei, Peng, Zhenwei, Shuai, Xintao, Guo, Yu
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2021
Assuntos:
Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8113035/
https://ncbi.nlm.nih.gov/pubmed/33674250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2021.101908
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares